Lung Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial

BACKGROUND: The 5-year overall survival rate of lung cancer patients is approximately 15%. Most patients are diagnosed with advanced-stage disease and have shorter survival rates than patients with early-stage disease. Although screening for lung cancer has the potential to increase early diagnosis,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hocking, William G., Hu, Ping, Oken, Martin M., Winslow, Stephen D., Kvale, Paul A., Prorok, Philip C., Ragard, Lawrence R., Commins, John, Lynch, David A., Andriole, Gerald L., Buys, Saundra S., Fouad, Mona N., Fuhrman, Carl R., Isaacs, Claudine, Yokochi, Lance A., Riley, Thomas L., Pinsky, Paul F., Gohagan, John K., Berg, Christine D.
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2010
Materias:
Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2873186/
https://ncbi.nlm.nih.gov/pubmed/20442215
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djq126
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares